Maintenance Notice

Due to necessary scheduled maintenance, the JMIR Publications website will be unavailable from Wednesday, July 01, 2020 at 8:00 PM to 10:00 PM EST. We apologize in advance for any inconvenience this may cause you.

Who will be affected?

Accepted for/Published in: JMIR Research Protocols

Date Submitted: Nov 1, 2023
Date Accepted: Jan 31, 2024

The final, peer-reviewed published version of this preprint can be found here:

Equity-Centered Postdischarge Support for Medicaid-Insured People: Protocol for a Type 1 Hybrid Effectiveness-Implementation Stepped Wedge Cluster Randomized Controlled Trial

Brooks-Carthon JM, Brom H, Grantham-Murrillo M, Sliwinski K, Mason A, Roeser M, Miles D, Garcia D, Bennett J, Harhay MO, Flores E, Amenyedor K, Clark R

Equity-Centered Postdischarge Support for Medicaid-Insured People: Protocol for a Type 1 Hybrid Effectiveness-Implementation Stepped Wedge Cluster Randomized Controlled Trial

JMIR Res Protoc 2024;13:e54211

DOI: 10.2196/54211

PMID: 38530349

PMCID: 11005441

Equity Centered Post Discharge Support for Medicaid Insured: Protocol for a Type 1 Hybrid Effectiveness Implementation Stepped-Wedge Cluster Randomized Trial

  • J. Margo Brooks-Carthon; 
  • Heather Brom; 
  • Marsha Grantham-Murrillo; 
  • Kathy Sliwinski; 
  • Aleigha Mason; 
  • Mindi Roeser; 
  • Donna Miles; 
  • Dianne Garcia; 
  • Jovan Bennett; 
  • Michael O. Harhay; 
  • Emilia Flores; 
  • Kelvin Amenyedor; 
  • Rebecca Clark

ABSTRACT

Background:

Disparities in posthospitalization outcomes for people with chronic medical conditions and insured by Medicaid are well documented, yet interventions that mitigate them are lacking. Prevailing transitional care interventions narrowly target people over age 65, with specific disease processes, or limitedly focus on individual-level behavioral change such as self-care or symptom management, thus failing to adequately provide a holistic approach to ensure an optimal post-hospital care continuum.

Objective:

The current study evaluates the implementation of THRIVE – an evidence-based, equity-focused clinical pathway that supports Medicaid-insured individuals with multiple chronic conditions transitioning from hospital to home by focusing on the social determinants of health and systemic and structural barriers in health care delivery. THRIVE services include coordinating care, standardizing interdisciplinary communication, and addressing unmet clinical and social needs following hospital discharge.

Methods:

Type I Hybrid Effectiveness-Implementation Stepped-Wedge Cluster Randomized Trial

Results:

This study was approved by the Institutional Review Board in January 2023 and launched in March 2023 with grant funding from the Rita and Alex Hillman Foundation. Recruitment and data collection began on March 27, 2023, and will be completed in December 2024. As of 10/31/23, 87 participants have been referred to the Thrive pathway for post discharge care support.

Conclusions:

The implementation and evaluation of the THRIVE clinical pathway will identify clinical supports and practice factors that influence success. Clinical Trial: ClinicalTrials.govNCT05714605. Registered February 6, 2023 – Implementation and Evaluation of a Health Innovation to Support Medicaid-Insured Individuals Following Hospitalization


 Citation

Please cite as:

Brooks-Carthon JM, Brom H, Grantham-Murrillo M, Sliwinski K, Mason A, Roeser M, Miles D, Garcia D, Bennett J, Harhay MO, Flores E, Amenyedor K, Clark R

Equity-Centered Postdischarge Support for Medicaid-Insured People: Protocol for a Type 1 Hybrid Effectiveness-Implementation Stepped Wedge Cluster Randomized Controlled Trial

JMIR Res Protoc 2024;13:e54211

DOI: 10.2196/54211

PMID: 38530349

PMCID: 11005441

Download PDF


Request queued. Please wait while the file is being generated. It may take some time.

© The authors. All rights reserved. This is a privileged document currently under peer-review/community review (or an accepted/rejected manuscript). Authors have provided JMIR Publications with an exclusive license to publish this preprint on it's website for review and ahead-of-print citation purposes only. While the final peer-reviewed paper may be licensed under a cc-by license on publication, at this stage authors and publisher expressively prohibit redistribution of this draft paper other than for review purposes.